Poliomyelitis (Polio) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 70 pages | ID: P0275E1FB3E9EN
VPAResearch

Abstracts

Poliomyelitis (Polio) Drug pipeline report- 2020 is an annual R&D review of Poliomyelitis (Polio) pipeline candidates. The report presents the current status of all major Poliomyelitis (Polio) therapeutic compounds. Detailed insights into Poliomyelitis (Polio) pipeline development, current status, companies, drug profiles and Poliomyelitis (Polio) preclinical and clinical trials are included.

2020 Poliomyelitis (Polio) Pipeline Market Insights
Poliomyelitis (Polio) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Poliomyelitis (Polio) therapies, pipeline by phase and others are included.

Poliomyelitis (Polio) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Poliomyelitis (Polio) Therapeutic Drug candidates
Both active and inactive Poliomyelitis (Polio) pipeline drug candidates are included in the report

Poliomyelitis (Polio) Clinical Trials and preclinical Studies
Poliomyelitis (Polio) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Poliomyelitis (Polio) pipeline market developments
Poliomyelitis (Polio) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Poliomyelitis (Polio) pipeline companies in active development
The report analyzes Poliomyelitis (Polio) pipeline of the below companies-

Batavia Biosciences, Beijing Minhai Biotechnology Co Ltd, Bharat Biotech Ltd, BIKEN Corp, Bilthoven Biologicals BV, Biological E Ltd, Biological Mimetics Inc, Boryung Pharmaceutical Co Ltd, GlaxoSmithKline Plc, Grifols SA, Johnson & Johnson, LG Chem Ltd, Panacea Biotec Ltd, Sanofi, Sanofi Pasteur SA, Sentinext Therapeutics Sdn Bhd, Takeda Pharmaceutical Co Ltd, Tianjin CanSino Biotechnology

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
18 Companies investing in Poliomyelitis (Polio) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Poliomyelitis (Polio) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. POLIOMYELITIS (POLIO) PIPELINE MARKET INSIGHTS, 2020

1.1 Poliomyelitis (Polio) Disease Overview
1.2 Poliomyelitis (Polio) Drug Pipeline Snapshot, 2020
  1.2.1 Poliomyelitis (Polio) Pipeline Drugs by Phase
  1.2.2 Poliomyelitis (Polio) Pipeline Drugs by Company
  1.2.3 Poliomyelitis (Polio) Pipeline Drugs by Mechanism of Action
  1.2.4 Poliomyelitis (Polio) Pipeline Drugs by Route of Administration

2. POLIOMYELITIS (POLIO) COMPANY WISE PIPELINE DETAILS

Batavia Biosciences Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Beijing Minhai Biotechnology Co Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Bharat Biotech Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
BIKEN Corp Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Bilthoven Biologicals BV Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biological E Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biological Mimetics Inc Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Boryung Pharmaceutical Co Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Grifols SA Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Johnson & Johnson Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
LG Chem Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Panacea Biotec Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Pasteur SA Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sentinext Therapeutics Sdn Bhd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Takeda Pharmaceutical Co Ltd Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tianjin CanSino Biotechnology Poliomyelitis (Polio) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. POLIOMYELITIS (POLIO) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. POLIOMYELITIS (POLIO) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts